Close

TPG invests $75 million into life sciences service firm

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

InterSystems and MyCLNQ Health Partner to Advance Patient Engagement Across Asia

Partnership helps hospitals to extend reach beyond existing facilities...

Medical Supplierz Links Healthcare Buyers and Manufacturers

Medical Supplierz, which happens to be a digital B2B procurement platform,...

AI-Led Warning System Prompts To Trigger CQC Inspection

The CQC is going to carry out rapid response...

Medtech Startup Raises $35M in Pulsed Field Ablation

Field Medical by Steven Mickelsen has gone on to...
The growth equity arm of buyout firm TPG Capital LP has invested $75 million in life sciences services company Precision for Medicine, according to people familiar with the matter, the latest in a string of TPG investments in the healthcare sector.

The sources asked not to be identified ahead of an announcement of the investment later on Tuesday.

Based in Bethesda, Maryland, Precision for Medicine helps pharmaceutical and life sciences companies develop and commercialize new drugs. The company was founded in 2013 by healthcare executives Ethan Leder and Mark Clein with $150 million in financing led by investment firms Oak Investment Partners, J.H. Whitney and Company, and LCI Capital.

TPG has invested steadily in the healthcare sector since the firm was founded in 1992 by David Bonderman and James Coulter. For example, it bought generic drugmaker Par Pharma for $1.9 billion in 2012 before selling it to pharmaceutical firm Endo International Plc for about $8 billion earlier this year.

TPG Growth manages more than $7 billion, while TPG has $70.2 billion of capital under management in total.

The global healthcare sector has seen a blitz of merger and acquisition activity this year that culminated in Pfizer Inc's $160 billion acquisition of Botox maker Allergan Plc in November, a deal that will create the world's largest drugmaker.

Latest stories

Related stories

InterSystems and MyCLNQ Health Partner to Advance Patient Engagement Across Asia

Partnership helps hospitals to extend reach beyond existing facilities...

Medical Supplierz Links Healthcare Buyers and Manufacturers

Medical Supplierz, which happens to be a digital B2B procurement platform,...

AI-Led Warning System Prompts To Trigger CQC Inspection

The CQC is going to carry out rapid response...

Medtech Startup Raises $35M in Pulsed Field Ablation

Field Medical by Steven Mickelsen has gone on to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back